The immune landscape of common CNS malignancies: implications for immunotherapy

M Ott, RM Prins, AB Heimberger - Nature Reviews Clinical Oncology, 2021 - nature.com
Immunotherapy has enabled remarkable therapeutic responses across cancers of various
lineages, albeit with some notable exceptions such as glioblastoma. Several previous …
被引用次数：62 相关文章

The immune landscape of common CNS malignancies: implications for immunotherapy.

M Ott, RM Prins, AB Heimberger - Nature reviews. Clinical Oncology, 2021 - europepmc.org
Immunotherapy has enabled remarkable therapeutic responses across cancers of various
lineages, albeit with some notable exceptions such as glioblastoma. Several previous …

The immune landscape of common CNS malignancies: implications for immunotherapy

M Ott, RM Prins, AB Heimberger - Nature reviews. Clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Immunotherapy has enabled remarkable therapeutic responses across cancers of various
lineages, albeit with some notable exceptions such as glioblastoma. Several previous …

The immune landscape of common CNS malignancies: implications for immunotherapy

M Ott, RM Prins, AB Heimberger - Nature Reviews …, 2021 - mdanderson.elsevierpure.com
Immunotherapy has enabled remarkable therapeutic responses across cancers of various
lineages, albeit with some notable exceptions such as glioblastoma. Several previous …

[引用][C] The immune landscape of common CNS malignancies: implications for immunotherapy

M Ott, RM Prins, AB Heimberger - Nature Reviews Clinical Oncology, 2021 - cir.nii.ac.jp
The immune landscape of common CNS malignancies: implications for immunotherapy |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …

The immune landscape of common CNS malignancies: implications for immunotherapy

M Ott, RM Prins, AB Heimberger - Nature Reviews …, 2021 - scholars.northwestern.edu
Immunotherapy has enabled remarkable therapeutic responses across cancers of various
lineages, albeit with some notable exceptions such as glioblastoma. Several previous …